Results 21 to 30 of about 1,899,013 (161)

Transcatheter Tricuspid Valve Intervention: Coaptation Devices [PDF]

Frontiers in Cardiovascular Medicine, 2020
Transcatheter tricuspid valve intervention (TTVI) has recently emerged as an alternative for the treatment of severe tricuspid regurgitation (TR). Multiple percutaneous devices have been developed in the last decade with promising early results.
Guillem Muntané-Carol, Alberto Alperi, Laurent Faroux, Elisabeth Bédard, François Philippon, Josep Rodés-Cabau   +5 more
openaire   +3 more sources

The Current Landscape of Transcatheter Tricuspid Valve Intervention

Journal of the Society for Cardiovascular Angiography & Interventions, 2023
Tricuspid regurgitation (TR) is common, and its prevalence increases with age. It was previously estimated that there are 1.6 million patients in the United States with moderate or worse TR, and more contemporary data suggest the age-adjusted prevalence of TR is 0.55%.
Henry Seligman, Amit N. Vora, Noah Q. Haroian, Rishi Puri, Ee Ling Heng, Robert D. Smith, Azeem Latib, Raj Makkar, Paul Sorajja, Martin B. Leon, Yousif Ahmad   +10 more
openaire   +2 more sources

Transcatheter Aortic Valve Implantation in Dialysis Patients [PDF]

, 2012
Background/Aims: Transcatheter aortic valve implantation (TAVI) has emerged as a new therapeutic option for high-risk patients. However, dialysis patients were excluded from all previous studies.
Wessely, Matthias, Schoenermarck, Ulf, Rau, Simon, Fischereder, Michael, Steinbeck, Gerhard, Kupatt, Christian, Lange, Philipp   +6 more
core   +1 more source

Expanding the Tools for Transcatheter Tricuspid Valve Intervention

JACC: Case Reports, 2020
[Figure: see text]
openaire   +3 more sources

Tricuspid Valve S-Curves and Chamber Views: Implications for Transcatheter Tricuspid and Pulmonary Valve Interventions, Part 2 of the S-Curves and Chamber Views Series. [PDF]

Despite the challenges associated with periprocedural imaging, transcatheter tricuspid valve interventions have shown important impact on outcomes. A comprehensive understanding of the anatomy of the right heart and surrounding structures is crucial. One
Tchetche, Didier, Maisano, Francesco, Al Ismaili, Abdullah, Afilalo, Jonathan, Sitges, Marta, Muraru, Denisa, Ho, Edwin, Mousavi, Negareh, Campens, Laurence, Buithieu, Jean, Duncan, Alison, Zamorano, José Luis, Hahn, Rebecca, Sarano, Maurice, Tournoux, François, Al Asmar, Mike, Chetrit, Michael, Modine, Thomas, van Mieghem, Nicolas, Coisne, Augustin, Gackowski, Andrzej, Quagliana, Angelo, Redwood, Simon, Dreyfus, Julien, Latib, Azeem, Praz, Fabien, Piazza, Nicolo, De Backer, Ole, Messika-Zeitoun, David, Choi, Calvin, Patterson, Tiffany, Fam, Neil, Wunderlich, Nina, Cavalcante, Joao, Delgado, Victoria, Prendergast, Bernard, Angiolillo, Dominick, Donal, Erwan, Medina de Chazal, Horacio A, Granada, Juan, Swaans, Martin, Spaziano, Marco, Von Bardeleben, Ralph Stephan, Zgheib, Ali, Martucci, Giuseppe, Ajmone-Marsan, Nina, Grapsa, Julia   +46 more
core   +3 more sources

Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. [PDF]

, 2012
BACKGROUND: Transcatheter aortic-valve replacement (TAVR) is the recommended therapy for patients with severe aortic stenosis who are not suitable candidates for surgery. The outcomes beyond 1 year in such patients are not known.
Makkar, Raj R, Dewey, Todd M, Pocock, Stuart, Brown, David L, Pichard, Augusto D, Bowers, Bruce, Siegel, Robert J, Smith, Craig R, Webb, John G, Tuzcu, Murat, Moses, Jeffrey W, Williams, Matthew R, Babaliaros, Vasilis C, Thourani, Vinod H, Kapadia, Samir, Svensson, Lars G, Jilaihawi, Hasan, Kodali, Susheel, Bavaria, Joseph E, MD, Fontana, Gregory P, Akin, Jodi J, Douglas, Pamela S, Bavaria, Joseph E, Herrmann, Howard C, Leon, Martin B, PARTNER Trial Investigators, Anderson, William N   +26 more
core   +1 more source

A Systematic Review of the Design, Method of Implantation and Early Clinical Outcomes of Transcatheter Tricuspid Prostheses

Reviews in Cardiovascular Medicine, 2023
Background: Intervention for tricuspid regurgitation (TR) tends to happen concurrently with and is addressed during mitral valve surgery. Isolated TR interventions, however, are not unusual and are becoming more common.
Faizus Sazzad, Yinling Zhu, Hwa Liang Leo, Jie Hui Nah, Hui Ying Ang, Chuen Neng Lee, Jimmy Kim Fatt Hon   +6 more
doaj   +1 more source

Indications, limitations, and development of tricuspid valve interventions in adults

, 2022
Tricuspid regurgitation is associated with excessive mortality and poor outcomes regardless of the cause and associated comorbidities. Despite this clear association with mortality, tricuspid valve diseases remain undertreated.
Ibrahim, Reda, Kresoja, Karl-Patrik, Perrin, Nils, Lurz, Philipp, Modine, Thomas, Ruf, Tobias, Bouhout, Ismail, Fam, Neil, Ben Ali, Walid, Stephan von Bardeleben, Ralph   +9 more
core   +1 more source

A Practical Approach to Combined Transcatheter Mitral and Tricuspid Valve Intervention [PDF]

Frontiers in Cardiovascular Medicine, 2021
Concomitant tricuspid regurgitation (TR) is common in patients with mitral regurgitation (MR). While current guidelines recommend repair of both valves at the time of surgery when feasible, high risk patients are often undertreated, leading to significant morbidity and mortality.
Lucas Burke, Magdi Hassanin, Geraldine Ong, Neil Fam   +3 more
openaire   +3 more sources

Transcatheter therapies for tricuspid valve regurgitation

, 2020
: Tricuspid regurgitation, either isolated or associated with left-valve disease, has a strong impact on outcome. Surgical treatment of tricuspid regurgitation has increased in recent years, but in-hospital mortality remains high probably due to the risk
Fiorina C., Metra M., Adamo M., Zaccone G., Di Pasquale M., Curello S.   +5 more
core   +1 more source